Home > Balance Sheet > INDO US BIOTECH

INDO US BIOTECH
Total Non-Current Liabilities

    Back to Balance Sheet
INDO US BIOTECH is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for INDO US BIOTECH
Please provide your vote to see the results

INDO US BIOTECH Last 5 Year Total Non-Current Liabilities History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
Total Non-Current Liabilities ₹3.59 Cr₹2.09 Cr₹4.07 Cr₹3.92 Cr₹1.52 Cr

What is the latest Total Non-Current Liabilities ratio of INDO US BIOTECH ?

The latest Total Non-Current Liabilities ratio of INDO US BIOTECH is ₹3.59 Cr based on Mar2024 Standalone results.
Year Total Non-Current Liabilities
Mar2024₹3.59 Cr
Mar2023₹2.09 Cr
Mar2022₹4.07 Cr
Mar2021₹3.92 Cr
Mar2020₹1.52 Cr

How is Total Non-Current Liabilities of INDO US BIOTECH Trending?

Years Total Non-Current Liabilities % Change
Mar2024 ₹3.59 Cr
71.41
Mar2023 ₹2.09 Cr
-48.61
Mar2022 ₹4.07 Cr
3.96
Mar2021 ₹3.92 Cr
157.12
Mar2020 ₹1.52 Cr -

Compare Total Non-Current Liabilities of peers of INDO US BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDO US BIOTECH ₹323.6 Cr -1% -18.2% -39.7% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹12,333.2 Cr 0% 4.6% 14.7% Stock Analytics
KAVERI SEED COMPANY ₹7,489.8 Cr 15.2% 43.4% 108.6% Stock Analytics
VENKYS (INDIA) ₹2,300.1 Cr 1.1% -0.1% 1.6% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,298.6 Cr 2.4% -4.8% -49.4% Stock Analytics
MANGALAM GLOBAL ENTERPRISE ₹452.8 Cr -9.3% -12.6% NA Stock Analytics


INDO US BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDO US BIOTECH

-1%

-18.2%

-39.7%

SENSEX

-2.9%

3.1%

1.8%


You may also like the below Video Courses